-
1 Comment
Winsan (Chengdu) Medical Science and Technology Co., Ltd is currently in a long term uptrend where the price is trading 81.0% above its 200 day moving average.
From a valuation standpoint, the stock is 24.6% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 12.0.
Winsan (Chengdu) Medical Science and Technology Co., Ltd's total revenue rose by 64.0% to $32M since the same quarter in the previous year.
Its net income has increased by 134.5% to $6M since the same quarter in the previous year.
Finally, its free cash flow grew by 164.4% to $10M since the same quarter in the previous year.
Based on the above factors, Winsan (Chengdu) Medical Science and Technology Co., Ltd gets an overall score of 4/5.
Sector | Technology |
---|---|
Industry | Software & IT Services |
Exchange | SHG |
CurrencyCode | CNY |
ISIN | CNE000000N89 |
Market Cap | 143M |
---|---|
PE Ratio | None |
Target Price | None |
Dividend Yield | 0.0% |
Beta | 0.56 |
Winsan (Chengdu) Medical Science and Technology Co., Ltd. engages in the medical and health care business in China. The company offers Situational Awareness Security Platform, which provides information security services for hospitals above the second level; and Commercial Insurance Claims Service Platform that offers online underwriting and claims services. It also provides consulting management services; and engages in the procurement and sales of medical reagents, medical equipment and consumables, and medical intelligent products. In addition, the company develops and manages real estate. The company was formerly known as Winsan (Shanghai) Medical Science and Technology Co., Ltd. and changed its name to Winsan (Chengdu) Medical Science and Technology Co., Ltd. in April 2020. The company was founded in 1993 and is headquartered in Chengdu, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 600767.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025